Epstein Secrets

CTORIA R KAUFMANN,MAXIMILLIAN LAVAN,SPENCER WOOLEMS,HEATHER ZEITZ,GLENN

CARPA,JOHN F COOLEY,WILLIAM O TRUMP,IVANA WAGNER,JOE GREENS PHARMACY R

by other forms of muscular dystrophy. "Muscle studies have been underfunded forever and certainly a rare disease like 2a especially underfunded," Spencer says. In 2010, Wrubel formed the nonprofit Coalition to Cure Calpain 3. In the quest for a cure, she says, "It's a matter of patients taking charg

mofmusculardystrophy, afamilyfindsanactivistleader,andhope BYJUDE ISABELLA I N 2007, AT HER high school graduation in Ques- nel, British Columbia, Ivana Topic stood at the top of the auditorium stairs, her long gown skimming — the floor, her dark brown hair spilling over her shoulders. She had on r

the stairs, very slowly, she hung on to her date. She was afraid her knees would collapse, as her muscles were weak for her age. From the audience, Ivana’s mother, Marijana, watched her daughter’s every step, silently panicking and breaking into a sweat. She knew Ivana could eas- ily tumble down the st

t from orphan drugs because, compared to drugs for common afflictions, they often have shorter and less expensive clinical trials, with more success. Spencer says a drug for calpamnopathy, for instance, would also be useful for patients with Lou Gehrig’s Disease and bed rest patients, as it would help arre

wed by other forms of muscular dystrophy. “Muscle studies have been underfunded forever and certainly a rare disease like 2a especially underfunded,” Spencer says. In 2010, Wrubel formed the nonprofit Coalition to Cure Calpain 3. In the quest for a cure, she says, “It’s a matter of patients taking charge